Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Pigmentation disorder
ADR ID BADD_A06054
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.05      Pigmentation disorders
23.05.03      Pigmentation changes NEC
23.05.03.001      Pigmentation disorder
Description Diseases affecting PIGMENTATION, including SKIN PIGMENTATION. [MeSH]
MedDRA Code 10062080
MeSH ID D010859; D010858; D012880
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Abnormal pigment | Abnormal pigmentation | Mottled pigmentation | Peri-nipple pigmentation | Pigmentation | Pigmentation abnormal | Pigmentation disorder NOS | Pigmentation skin | Sin pigmentation | Skin pigmentation | Spot pigmented | Pigmentation disorder | Chromatosis | Pigmentation Disorders | Disorder, Pigmentation | Disorders, Pigmentation | Pigmentation Disorder | Schamberg Disease | Disease, Schamberg | Schamberg's Disease | Disease, Schamberg's | Schambergs Disease | Ito Syndrome | Syndrome, Ito | Incontinentia Pigmenti Achromians
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02150Temozolomide--
BADD_D02165Teriflunomide0.001881%
BADD_D02184Tetraferric tricitrate decahydrate0.004213%
BADD_D02192Thalidomide0.000820%
BADD_D02201Thioridazine hydrochloride--
BADD_D02203Thiotepa--
BADD_D02220Timolol maleate--
BADD_D02236Tofacitinib--
BADD_D02257Trametinib0.000571%
BADD_D02272Triamcinolone acetonide0.000027%
BADD_D02281Trifluoperazine--
BADD_D02282Trifluoperazine hydrochloride--
BADD_D02331Valsartan0.000106%
BADD_D02344Vemurafenib0.000302%
BADD_D02362Vinflunine--
BADD_D02369Voriconazole0.011617%
BADD_D02383Zidovudine--
BADD_D02398Zuclopenthixol--
BADD_D02412Octreotide0.000410%
BADD_D02440Lisdexamfetamine0.000153%
BADD_D02450Crisaborole0.001897%
BADD_D02464Fingolimod0.002194%
BADD_D02483Ribociclib0.000168%
BADD_D02515Pexidartinib0.000571%
The 4th Page    First    Pre   4    Total 4 Pages